These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


474 related items for PubMed ID: 17200247

  • 1. The economics of routine childhood hepatitis A immunization in the United States: the impact of herd immunity.
    Armstrong GL, Billah K, Rein DB, Hicks KA, Wirth KE, Bell BP.
    Pediatrics; 2007 Jan; 119(1):e22-9. PubMed ID: 17200247
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T, Abrahamsen TG, Bergsaker MA, Løvoll Ø, Møller P, Pedersen MK, Kristiansen IS.
    Vaccine; 2006 Jul 17; 24(29-30):5690-9. PubMed ID: 16735083
    [Abstract] [Full Text] [Related]

  • 6. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales.
    Melegaro A, Edmunds WJ.
    Vaccine; 2004 Oct 22; 22(31-32):4203-14. PubMed ID: 15474710
    [Abstract] [Full Text] [Related]

  • 7. Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.
    Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.
    Arch Pediatr Adolesc Med; 2005 Dec 22; 159(12):1136-44. PubMed ID: 16330737
    [Abstract] [Full Text] [Related]

  • 8. Cost-effectiveness of heptavalent conjugate pneumococcal vaccine (Prevenar) in Germany: considering a high-risk population and herd immunity effects.
    Lloyd A, Patel N, Scott DA, Runge C, Claes C, Rose M.
    Eur J Health Econ; 2008 Feb 22; 9(1):7-15. PubMed ID: 17333089
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of universal childhood hepatitis A vaccination in Chile.
    Valenzuela MT, Jacobs RJ, Arteaga O, Navarrete MS, Meyerhoff AS, Innis BL.
    Vaccine; 2005 Jul 14; 23(32):4110-9. PubMed ID: 15964479
    [Abstract] [Full Text] [Related]

  • 10. The impact of indirect (herd) protection on the cost-effectiveness of pneumococcal conjugate vaccine.
    Isaacman DJ, Strutton DR, Kalpas EA, Horowicz-Mehler N, Stern LS, Casciano R, Ciuryla V.
    Clin Ther; 2008 Feb 14; 30(2):341-57. PubMed ID: 18343273
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness of conjugate meningococcal vaccination strategies in the United States.
    Shepard CW, Ortega-Sanchez IR, Scott RD, Rosenstein NE, ABCs Team.
    Pediatrics; 2005 May 14; 115(5):1220-32. PubMed ID: 15867028
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The cost effectiveness of hepatitis immunization for US college students.
    Jacobs RJ, Saab S, Meyerhoff AS.
    J Am Coll Health; 2003 May 14; 51(6):227-36. PubMed ID: 14510025
    [Abstract] [Full Text] [Related]

  • 14. The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.
    Griffiths UK, Hutton G, Das Dores Pascoal E.
    Health Policy Plan; 2005 Jan 14; 20(1):50-9. PubMed ID: 15689430
    [Abstract] [Full Text] [Related]

  • 15. An economic analysis of different strategies of immunization against hepatitis A virus in developed countries.
    Das A.
    Hepatology; 1999 Feb 14; 29(2):548-52. PubMed ID: 9918934
    [Abstract] [Full Text] [Related]

  • 16. Cost-effectiveness analysis of a rotavirus immunization program for the United States.
    Smith JC, Haddix AC, Teutsch SM, Glass RI.
    Pediatrics; 1995 Oct 14; 96(4 Pt 1):609-15. PubMed ID: 7567319
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Economic evaluation of an infant immunization program in Mexico, based on 13-valent pneumococcal conjugated vaccines].
    Muciño-Ortega E, Mould-Quevedo JF, Farkouh R, Strutton D.
    Value Health; 2011 Oct 14; 14(5 Suppl 1):S65-70. PubMed ID: 21839902
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis A in the era of vaccination.
    Wasley A, Fiore A, Bell BP.
    Epidemiol Rev; 2006 Oct 14; 28():101-11. PubMed ID: 16775039
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.